Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2014 Publisher: Mitsubishi Tanabe Pharma Europe Limited, 6<sup>th</sup> Floor, Dashwood House, 69 Old Broad Street, London, EC2M 1QS, United Kingdom
Tanatril 5 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablets. Off-white oblong biconvex tablets with a plane edge, scored on both sides. The tablet can be divided into equal doses. |
Imidapril hydrochloride 5 mg.
Excipient with known effect: Lactose, 54 mg per tablet.
For the full list of excipients, see section 6.1
| Active Ingredient | Description | |
|---|---|---|
| Imidapril |
The hypotensive effect of imidapril in hypertension appears to result primarily from the suppression of the plasma renin-angiotensin-aldosterone system. |
| List of Excipients |
|---|
|
Calcium hydrogen phosphate, anhydrous |
Aluminium/aluminium or PVDC/aluminium – Blister with 5, 7 and 10 tablets.
Packs with 7, 10, 14, 15, 20, 28, 30, 50, 56, 84, 90, 100, and 1000 tablets
Not all packaging material or pack sizes may be marketed.
Mitsubishi Tanabe Pharma Europe Limited, 6th Floor, Dashwood House, 69 Old Broad Street, London, EC2M 1QS, United Kingdom
PL 20012/0004
12/November/2007
| Drug | Countries | |
|---|---|---|
| TANATRIL | Austria, Hong Kong, Japan, Poland, Singapore, Tunisia, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
